# Bleomycin

NDC: 0143-9241
Generic name: Bleomycin
Labeler / Manufacturer: Hikma Pharmaceuticals USA Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Routes: INTRAMUSCULAR, INTRAPLEURAL, INTRAVENOUS, SUBCUTANEOUS
Marketing started: 20180109

FDA application: ANDA065042

## Active ingredients

- BLEOMYCIN SULFATE: 30 [USP'U]/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0143-9241"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0143-9241
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=cccfb763-79fa-4186-89fb-d8d061d3c161